Larkspur Health Acquisition, a blank check company focused on the US biotechnology sector, filed on Thursday with the SEC to raise up to $75 million in an initial public offering.
The Bridgewater, NJ-based company plans to raise $75 million by offering 7.5 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. At the proposed deal size, Lakespur Health Acquisition would command a market value of $96 million.
The company is led by CEO and Chairman Daniel O'Connor, the CEO of immuno-oncology biotech OncoSec Medical (Nasdaq: ONCS), and CFO David Briones, the founder and Managing Member of financial consulting firm Brio Financial Group.
Lakespur Health Acquisition was founded in 2021 and plans to list on the Nasdaq under the symbol LSPRU. A.G.P. is the lead bookrunner on the deal.
